Alto Neuroscience, Inc. (ANRO) Operating cash flow 2023–2025
Alto Neuroscience, Inc. (ANRO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$51.8MFY2025 · since FY2023: -$33.4M → -$51.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.8M | -9.2% |
| FY2024 | -$47.4M | -41.8% |
| FY2023 | -$33.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice